|
|
|
|
The successful transition from initial synthesis of an API to a kilogram-scale route requires expert analysis and design, and a balance of economic, regulatory, and time constraints.
|
|
|
|
|
Whether performed during formation of an API or as a means to purify intermediates, achieving control of nucleation and crystal growth is critical to designing a successful peptide crystallization process.
|
|
|
|
|
|
|
Cy Credille, Group Leader in Process Chemistry at Cambrex Longmont, details the setbacks that come in early development — and why working with a team that has seen them all before can be the fastest route to the IND finish line.
|
|
|
|
|
Daniele Vigo, Assistant Director at Cambrex Milan, shares how development teams can improve yield, purity, and scalability while maintaining budget discipline and avoiding costly rework.
|
|
|
|
|
Greg Buenger, Group Leader of Chemical Development at Cambrex Charles City, discusses what successful technology transfer looks like: chemists on the floor for the first batch, guiding operators and solving problems in real time.
|
|
|
|
|
|
|
See how Cambrex’s innovative capabilities and advanced technologies can optimize the development and manufacturing of complex synthetics.
|
|
|
